Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Hack Andrew A. F.
Relationship:  
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   25,181    

Indirect Shares

   18,379,099      
Direct Value   $156,464    

Indirect Value

   $35,933,454      
Total Shares   18,404,280      
Total Value   $36,089,918      


Dynavax Technologies Corp $122,032 Mersana Therapeutics, Inc. $34,431 Dynavax Technologies Corp $122,032 Mersana Therapeutics, Inc. $34,431
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    20   
    7    

     Stock price went up :
    17   
    3    
     Stock price went down :
    3   
    4    
   
     Gain/Loss Ratio :
   5.7   
   5.7   
     Percentage Gain/Loss :
   61.2%
 -72.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Editas Medicine, Inc. EDIT Chief Financial Officer 2019-02-04 0 2017-02-15 0    Premium*  
            Dynavax Technologies Corp DVAX 2023-08-08 10,714 2023-08-08 915,000    Premium*  
            Mersana Therapeutics, Inc. MRSN Director 2023-06-08 14,467 2023-06-08 8,663,673    Premium*  
            Bcls Acquisition Corp. BLSA Chief Financial Office... 2020-10-26 0 2020-10-26 487,500    Premium*  
            Atea Pharmaceuticals, Inc. AVIR Director 2020-11-03 0 2020-11-03 5,615,659    Premium*  
            Nuvalent, Inc. NUVL 2021-08-02 0 2024-03-27 2,697,267    Premium*  
* Premium Members only  

Records found :    80         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
EDIT Editas Medicine, Inc. Chief Financial Officer   •       –      –    2018-06-01 4 AS $39.05 $274,970 D/D (7,000) 0 0 -
EDIT Editas Medicine, Inc. Chief Financial Officer   •       –      –    2018-06-04 4 AS $37.10 $111,300 D/D (3,000) 0 0 -
EDIT Editas Medicine, Inc. Chief Financial Officer   •       –      –    2018-06-04 4 OE $24.60 $73,800 D/D 3,000 3,000 0 -
EDIT Editas Medicine, Inc. Chief Financial Officer   •       –      –    2018-08-31 4 OE $6.48 $64,800 D/D 10,000 10,000 0 -
EDIT Editas Medicine, Inc. Chief Financial Officer   •       –      –    2018-08-31 4 AS $32.23 $322,300 D/D (10,000) 0 0 -
EDIT Editas Medicine, Inc. Chief Financial Officer   •       –      –    2018-09-28 4 AS $32.08 $256,640 D/D (8,000) 0 0 -
EDIT Editas Medicine, Inc. Chief Financial Officer   •       –      –    2018-09-28 4 OE $6.48 $51,840 D/D 8,000 8,000 0 -
EDIT Editas Medicine, Inc. Chief Financial Officer   •       –      –    2018-10-26 4 OE $6.48 $38,880 D/D 6,000 6,000 0 -
EDIT Editas Medicine, Inc. Chief Financial Officer   •       –      –    2018-10-26 4 AS $25.70 $154,200 D/D (6,000) 0 0 -
EDIT Editas Medicine, Inc. Chief Financial Officer   •       –      –    2018-11-23 4 OE $6.48 $34,240 D/D 5,284 5,284 0 -
EDIT Editas Medicine, Inc. Chief Financial Officer   •       –      –    2018-11-23 4 AS $28.14 $148,739 D/D (5,284) 0 0 -
EDIT Editas Medicine, Inc. Chief Financial Officer   •       –      –    2019-01-04 4 OE $6.48 $45,360 D/D 7,000 7,000 0 -
EDIT Editas Medicine, Inc. Chief Financial Officer   •       –      –    2019-01-04 4 AS $22.48 $157,360 D/D (7,000) 0 0 -
EDIT Editas Medicine, Inc. Chief Financial Officer   •       –      –    2019-02-04 4 OE $6.48 $44,680 D/D 6,895 6,895 0 -
EDIT Editas Medicine, Inc. Chief Financial Officer   •       –      –    2019-02-04 4 AS $21.39 $147,484 D/D (6,895) 0 0 -
DVAX Dynavax Technologies Corp Director   –       •      –    2019-08-12 3 IO $0.00 $0 I/I 0 7,525,000 -
MRSN Mersana Therapeutics, Inc... Director   –       •      –    2020-04-07 4 B $5.59 $20,649,463 I/I 3,445,667 3,445,667 2.1 %
DVAX Dynavax Technologies Corp Director   –       •      –    2020-05-27 4 B $5.00 $5,000,000 I/I 1,000,000 8,525,000 2.1 %
BLSA Bcls Acquisition Corp. Chief Financial Officer   •       •       •   2020-10-26 4 A $10.00 $4,875,000 I/I 487,500 487,500 0 -
AVIR Atea Pharmaceuticals, Inc... Director   –       •      –    2020-11-03 4 A $0.00 $0 I/I 5,365,659 5,365,659 0 -
AVIR Atea Pharmaceuticals, Inc... Director   –       •      –    2020-11-03 4 B $24.00 $6,000,000 I/I 250,000 5,615,659 2.1 -
MRSN Mersana Therapeutics, Inc... Director   –       •      –    2021-01-08 4 B $18.39 $1,839,000 I/I 100,000 3,545,667 2.1 %
MRSN Mersana Therapeutics, Inc... Director   –       •      –    2021-01-11 4 B $18.52 $1,389,000 I/I 75,000 3,620,667 2.1 %
MRSN Mersana Therapeutics, Inc... Director   –       •      –    2021-01-12 4 B $18.16 $1,362,000 I/I 75,000 3,695,667 2.1 %
NUVL Nuvalent, Inc. Director   –       •      –    2021-08-02 4 B $17.00 $12,495,000 I/I 735,000 3,428,014 2.1 -
  80  Records found
  1   2  3   4      
  Page 2 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us